| 12497405 |
Bicyclic heterocycle compounds methods of use thereof for the treatment of herpes viruses |
Brendan M. Crowley, Marc A. Labroli, Michael A. Plotkin, Izzat T. Raheem, Ling Tong +1 more |
2025-12-16 |
|
| 9914736 |
TrKA kinase inhibitors, compositions and methods thereof |
Helen J. Mitchell, Mark E. Fraley, Craig A. Stump, Xu-Fang Zhang, Casey Cameron McComas +6 more |
2018-03-13 |
$78,687,000 |
| 9896447 |
TrkA kinase inhibitors, compositions and methods thereof |
Craig A. Stump, Xu-Fang Zhang, Chun Sing Li, Qinghua Mao |
2018-02-20 |
$282,753,000 |
| 9862716 |
TRKA kinase inhibitors, compositions and methods thereof |
Helen J. Mitchell, Mark E. Fraley, Craig A. Stump, Yi-Heng Chen, Xu-Fang Zhang +10 more |
2018-01-09 |
$60,079,000 |
| 9844553 |
Pyrazolopyridyl compounds as aldosterone synthase inhibitors |
D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Scott B. Hoyt, Clare London +6 more |
2017-12-19 |
$150,910,000 |
| 9815846 |
TrkA kinase inhibitors, compositions and methods thereof |
Helen J. Mitchell, Mark E. Fraley, Craig A. Stump, Yi-Heng Chen, Xu-Fang Zhang +13 more |
2017-11-14 |
$82,691,000 |
| 9718782 |
TrkA kinase inhibitors, compositions and methods thereof |
Craig A. Stump, Xu-Fang Zhang, Chun Sing Li, Qinghua Mao |
2017-08-01 |
$68,609,000 |
| 9567333 |
Triazolopyridyl compounds as aldosterone synthase inhibitors |
D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Scott B. Hoyt, Clare London +6 more |
2017-02-14 |
$97,202,000 |
| 9550786 |
4-fluoropiperidine orexin receptor antagonists |
Scott D. Kuduk, Craig A. Stump, Peter D. Williams |
2017-01-24 |
$89,126,000 |
| 9522141 |
Indazole compounds as aldosterone synthase inhibitors |
Scott B. Hoyt, Jerry Andrew Taylor, Clare London, Yusheng Xiong |
2016-12-20 |
$135,614,000 |
| 9518055 |
Imidazopyridyl compounds as aldosterone synthase inhibitors |
Amjad Ali, D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Scott B. Hoyt +8 more |
2016-12-13 |
$109,867,000 |
| 9382226 |
Aldosterone synthase inhibitors |
Scott B. Hoyt, Min K. Park, Clare London, Yusheng Xiong, D. Jonathan Bennett +7 more |
2016-07-05 |
$61,670,000 |
| 9351973 |
Pyrazolopyridyl compounds as aldosterone synthase inhibitors |
D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Scott B. Hoyt, Clare London +6 more |
2016-05-31 |
$68,752,000 |
| 9193724 |
Triazolopyridyl compounds as aldosterone synthase inhibitors |
D. Jonathan Bennett, Jaiqiang Cai, Emma Carswell, Scott B. Hoyt, Clare London +6 more |
2015-11-24 |
$115,122,000 |
| 9108939 |
(1, 1, 1,3,3,3-hexafluoro-2 hydroxypropan-2-yl) phenyl derivative, pharmaceutical compositions thereof and their use for the treatment of atherosclerosis |
Emma Carswell, David Jonathan Bennett |
2015-08-18 |
$66,173,000 |
| 8759352 |
1-(4-ureidobenzoyl)piperazine derivatives |
David Jonathan Bennett, Andrew Stanley Edwards, Andrew Roughton, Irina Neagu, Jui-Hsiang Chan +5 more |
2014-06-24 |
$70,429,000 |
| 8357679 |
Hexafluoroisopropanol derivatives |
Andrew Stanley Edwards, Fiona Elizabeth Andrews, David Jonathan Bennett, Olaf Nimz, Emma Carswell |
2013-01-22 |
|
| 8314091 |
N-benzyl,N'-arylcarbonylpiperazine derivatives |
Koc-Kan Ho, Andrew Roughton, Irina Neagu, Jui-Hsiang Chan, Nasrin Ansari +5 more |
2012-11-20 |
|
| 7700638 |
1,5,7-trisubstituted benzimidazole derivatives and their use for modulating the GABAA receptor complex |
Niall Hamilton, Susan Elizabeth Napier, Morag Ann MacCall Easson, Lene Teuber, Naheed Mirza +1 more |
2010-04-20 |
|
| 6984644 |
Treatment of skin disorders using thieno[2,3-D]pyrimidinediones |
David Cheshire, Martin Cooper, David Donald, Mark Furber, Matthew Perry +1 more |
2006-01-10 |
$11,289,000 |
| 6469014 |
Thieno[2,3-d] pyrimidinediones, their preparation and use in therapy |
David Cheshire, Martin Cooper, David Donald, Mark Furber, Matthew Perry +1 more |
2002-10-22 |
$9,564,000 |
| 6342502 |
Thieno[2,3-d]pyrimidine diones and their use in the treatment of reversible obstructive airways diseases |
David Cheshire, Martin Cooper, David Donald, Mark Furber, Matthew Perry +1 more |
2002-01-29 |
$7,875,000 |
| 6180635 |
Compounds |
David Cheshire, Martin Cooper, David Donald, Mark Furber, Matthew Perry +1 more |
2001-01-30 |
$18,992,000 |
